Rowan Miller

ORCID: 0000-0002-2400-1716 · 1 paper in corpus
other 2022
Cancer immunology research ·doi:10.1158/2326-6066.CIR-22-0407

Some patients with advanced clear-cell ovarian cancer (CCOC) respond to immunotherapy; however, little is known about the tumor microenvironment (TME) of this relatively rare disease. Here, we describe a comprehensive quantitative and topog…